BIOMAT Database Logo BIOMAT Database Logo

[Tris-(hydroxymethyl)aminomethane (THAM) for therapy of acidosis in children]. 1966

G Vercruysse, and G Weissenbacher, and E Zweymüller

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D001803 Blood Transfusion The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed) Blood Transfusions,Transfusion, Blood,Transfusions, Blood
D002056 Burns Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like. Burn
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations

Related Publications

G Vercruysse, and G Weissenbacher, and E Zweymüller
The pharmacology of tris(hydroxymethyl) aminomethane (THAM).
September 1962, Pharmacological reviews,
G Vercruysse, and G Weissenbacher, and E Zweymüller
The treatment of acidosis in acute lung injury with tris-hydroxymethyl aminomethane (THAM).
April 2000, American journal of respiratory and critical care medicine,
G Vercruysse, and G Weissenbacher, and E Zweymüller
THE CLINICAL PHARMACOLOGY OF THAM (TRIS(HYDROXYMETHYL)AMINOMETHANE).
January 1963, Clinical pharmacology and therapeutics,
G Vercruysse, and G Weissenbacher, and E Zweymüller
Tris (hydroxymethyl) aminomethane (THAM)-a new buffer for therapeutic use.
January 1962, American journal of diseases of children (1960),
G Vercruysse, and G Weissenbacher, and E Zweymüller
Evaluation of tris (hydroxymethyl) aminomethane (THAM) in experimental hemorrhagic shock.
July 1963, Surgery,
G Vercruysse, and G Weissenbacher, and E Zweymüller
The correction of acidosis with tris(hydroxymethyl) aminomethane. Treatment of metabolic acidosis mixed respiratory and metabolic acidosis with tris(hydroxymethyl) aminomethane.
April 1960, Archives of surgery (Chicago, Ill. : 1960),
G Vercruysse, and G Weissenbacher, and E Zweymüller
Anuria of hypovolemic shock relieved by tris (hydroxymethyl) aminomethane (THAM).
June 1961, Surgery, gynecology & obstetrics,
G Vercruysse, and G Weissenbacher, and E Zweymüller
Evaluation of antacid activity for metal complexes of tris(hydroxymethyl)aminomethane (THAM).
February 1967, Journal of pharmaceutical sciences,
G Vercruysse, and G Weissenbacher, and E Zweymüller
[Effect of tris(hydroxymethyl) aminomethane (THAM) on kidney circulation in hemorrhagic shock].
November 1965, Pflugers Archiv fur die gesamte Physiologie des Menschen und der Tiere,
G Vercruysse, and G Weissenbacher, and E Zweymüller
[THE USE OF TRIS(HYDROXYMETHYL)AMINOMETHANE (THAM) IN THE TREATMENT OF SEVERE BURNS].
May 1964, La Presse medicale,
Copied contents to your clipboard!